Literature DB >> 6088664

Expression of Tac antigen on activated normal human B cells.

M Tsudo, T Uchiyama, H Uchino.   

Abstract

Two-color fluorescence analysis revealed that Tac antigen, which was previously reported to be restricted to T cells, was expressed on a proportion of normal B cells activated by Staphylococcus aureus Cowan I (SAC). Immunoaffinity-purified interleukin 2 (IL-2) induced the proliferation of SAC-activated B cells, and the proliferation was completely inhibited by anti-Tac antibody, which blocked the membrane binding and action of IL-2. These results suggest that an IL-2 receptor system is directly involved in the B cell immune response.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6088664      PMCID： PMC2187446          DOI： 10.1084/jem.160.2.612

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  12 in total

1.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

2.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

3.  Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF).

Authors:  A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.

Authors:  M Howard; L Matis; T R Malek; E Shevach; W Kell; D Cohen; K Nakanishi; W E Paul
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

5.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

Authors:  S J Korsmeyer; W C Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; W J Leonard; E S Jaffe; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.

Authors:  K A Smith; M F Favata; S Oroszlan
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells.

Authors:  H J Liebson; P Marrack; J Kappler
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Fluorescent phycobiliprotein conjugates for analyses of cells and molecules.

Authors:  V T Oi; A N Glazer; L Stryer
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

9.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.

Authors:  R J Robb; W C Greene
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307
View more
  74 in total

1.  The proliferation rate of T and B lymphocytes in cerebrospinal fluid.

Authors:  R S Thomas; W Beuche; K Felgenhauer
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

2.  Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.

Authors:  L Chatenoud; B Dugas; G Beaurain; M Touam; T Drueke; A Vasquez; P Galanaud; J F Bach; J F Delfraissy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  T lymphocyte activation state in the minor salivary glands of patients with Sjögren's syndrome.

Authors:  M Segerberg-Konttinen; V Bergroth; P Jungell; M Malmström; D Nordström; J Sane; I Immonen; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

4.  Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.

Authors:  R J Armitage; J C Cawley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

5.  Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G Semenzato; L M Bambara; D Biasi; A Frigo; F Vinante; B Zuppini; L Trentin; C Feruglio; M Chilosi; G Pizzolo
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

6.  Expression of Tac antigen in B cell lymphomas.

Authors:  G Laurent; T Al Saati; D Olive; J C Laurent; P Poncelet; G Delsol
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

Review 7.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

8.  Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.

Authors:  S Kakumu; K Yoshioka; A Fuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1988-08

9.  Role of interferon-gamma on the in vivo expression of functional interleukin-2 receptors by murine macrophages.

Authors:  B Dugas; L Friteau; H Schellekens; D Lando; C Damais
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

10.  Comparative study of intracellular glutathione content in rat lymphocyte cultures treated with 2-mercaptoethanol and interleukin-2.

Authors:  A Aidoo; L E Lyn-Cook; S M Morris; R L Kodell; D A Casciano
Journal:  Cell Biol Toxicol       Date:  1991-07       Impact factor: 6.691
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.